40 Catalent Staff Laid Off in UK
EMPLOYEES at a pharmaceutical company have been dealt a massive blow just weeks before Christmas, as it was announced dozens of staff would lose their jobs. More than 40 staff at Catalent have been told this week that they are to be without a job by the end of the year, along with several temporary […]
Read More »Category : News
Thai pharma manager murdered in UK ‘A friend to all’
The body of Khanokporn Satjawat, 42, was found in the female toilets at the the Scottish Exhibition and Conference Centre in Glasgow where she was attending the 11th International Congress on Drug Therapy in HIV Infection. Her body was found in a pool of blood and she had suffered blows to the head and body. […]
Read More »Category : News
Novartis Vaccine Wins Approval for Meningitis B
source In a move that gives Novartis executives hope that they may yet compete in the global vaccines market, the European Medicines Agency has approved the first vaccine that is designed to combat meningitis B, which is the most common strain of meningococcal disease. The approval allows the vaccine to be used in people as […]
Read More »Category : News
FDA Wants to See Two Classes of Compounding
source As FDA commish Margaret Hamburg braces herself for questioning from members of Congress during hearings today and tomorrow about the compounding pharmacy controversy, the agency is proposing that two forms of compounding should be created so that higher-risk production can be more closely regulated (watch the hearing at 10 am EST right here). […]
Read More »Category : News
Did This Clinical Trial Succeed or Fail?
Source Did a clinical trial for an opioid constipation medicine being developed by AstraZeneca and Nektar Therapeutics actually fail even, though the drugmakers maintained that “positive†top-line results were harvested? The possibility was raised courtesy of a reference in a press release that the trial database was unlocked and then locked again prior to analysis. […]
Read More »Category : News
Breaking News – Lipitor Whistleblower Suit Against Pfizer Dismissed
Source A federal judge has dismissed a long-running whistleblower lawsuit filed by a former Pfizer executive, who accused the drugmaker of illegally scheming to boost Lipitor sales by misrepresenting product labeling and federal cholesterol guidelines; using misleading educational programs for doctors; unlawful sampling, and kickback schemes that resulted in off-label marketing that allegedly defrauded Medicaid […]
Read More »Category : News
More Inspection Problems At Other Compounding Plants
Source In the latest bit of evidence to raise disturbing questions about some compounding pharmacy operations and regulatory oversight, the FDA recently sent 14 investigators and three microbiologists to inspect Ameridose, which is owned by the same folks who own the New England Compounding Center, and found another remarkable series of troubling findings. Such as? […]
Read More »Category : News
Bristol Meyers Cuts Another 100 Jobs
Source Less than a month after disclosing plans to eliminate nearly 500 jobs, Bristol-Myers Squibb is chopping another 100 or so positions from various departments and locations as the drugmaker attempts to adjust to a changing product portfolio, pricing challenges and assorted setbacks. The latest layoffs numbers in the dozens and involve field sales, medical […]
Read More »Category : News
Should There Be Mandatory Audits for All API Suppliers?
Source A European trade group that represents chemical manufacturers believes that European Union efforts to safely oversee active pharmaceutical ingredient production in other regions is sorely lacking and now wants inspections of all API manufacturing facilities around the world to become mandatory. The European Fine Chemicals Group argues that recent legislative efforts, including those aimed […]
Read More »Category : News
Bristol Myers Cuts 500 More Jobs
And the parade of layoffs continues. The latest drugmaker to shed some workers is Bristol-Myers Squibb, which plans to eliminate 479 sales reps and related jobs now that Otsuka Pharmaceuticals will assume responsbility for marketing the Abilify antipsycotic in the US, a spokeswoman tells us. The job cuts were disclosed in a state notice. The […]
Read More »Category : News
